CURE Pharmaceutical has named Vered Gigi as vice president of strategy and business development. The appointment is part of a larger push to build out partnerships within the pharmaceutical industry and test new indications for the company’s primary product.
“CURE has been on stealth mode for a while, developing the technology and the intellectual property,” Gigi said. “Now we’re really moving into phase two of growth and expansion to bring our product to market.”
Read the full article here. (San Fernando Valley Business Journal)